Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
Clinical trial NCT04115748 · TERMINATED
Trial details
- NCT number
- NCT04115748
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2021-01-19
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.